Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-29 @ 3:19 AM
Study NCT ID:
NCT00635193
Status:
COMPLETED
Last Update Posted:
2013-01-18
First Post:
2008-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-05
First Submit QC Date:
None
Study First Post Date:
2008-03-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-05-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-01-10
Last Update Post Date:
2013-01-18
Last Update Post Date Type:
ESTIMATED